Avanos Medical Share Price Today
(NASDAQ: AVNS)

Name: Avanos Medical Share Price Today (NASDAQ: AVNS) - Avanos Medical Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Avanos Medical share price is $14.82 & ₹1,282.15 as on 20 Mar 2025, 2.30 'hrs' IST

$14.82

▲

0.19

(1.3%)

Market is closed - opens 7 PM, 20 Mar 2025

View live Avanos Medical share price in Dollar and Rupees. Guide to invest in Avanos Medical stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Avanos Medical, along with analyst recommendations, forecasts, and comprehensive financials.

Avanos Medical share price movements

Today's Low: $14.48
Today's High: $14.84
$14.82
2.33%
Downside
Day's Volatility :2.46%
Upside
0.13%
52 Weeks Low: $14.25
52 Weeks High: $25.36
$14.82
3.85%
Downside
52 Weeks Volatility :43.81%
Upside
41.56%

Avanos Medical (AVNS) Returns

Period	Avanos Medical, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-10.4%	-9999999.0%	0.0%
6 Months	-39.98%	-9999999.0%	0.0%
1 Year	-24.16%	-9999999.0%	0.0%
3 Years	-53.92%	-9999999.0%	-15.2%

Avanos Medical (AVNS) Key Statistics

in dollars & INR

Previous Close	$14.63
Open	$14.62
Today's High	$14.84
Today's Low	$14.475
Market Capitalization	$681.8M
Today's Volume	$737.2K
52 Week High	$25.36
52 Week Low	$14.25
Revenue TTM	$687.8M
EBITDA	$90.3M
Earnings Per Share (EPS)	$-8.4
Profit Margin	-57.01%
Quarterly Earnings Growth YOY	-0.37%
Return On Equity TTM	-37.42%

How to invest in Avanos Medical Stock (AVNS) from India?

It is very easy for Indian residents to invest directly in Avanos Medical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Avanos Medical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Avanos Medical or AVNS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Avanos Medical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Avanos Medical shares which would translate to 0.058 fractional shares of Avanos Medical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Avanos Medical, in just a few clicks!

Returns in Avanos Medical (AVNS) for Indian investors in Rupees

The Avanos Medical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Avanos Medical investment value today

Current value as on today

₹79,912

Returns

₹20,088

(-20.09%)

Returns from Avanos Medical Stock

₹24,156 (-24.16%)

Dollar Returns

₹4,068 (+4.07%)

Indian investors sentiment towards Avanos Medical (AVNS)

125%

Period: Feb 17, 2025 to Mar 19, 2025. Change in 30 Days versus previous period

Search interest for Avanos Medical Stock from India on INDmoney has increased by 125% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Avanos Medical

BlackRock Inc
15.55%
Vanguard Group Inc
11.61%
T. Rowe Price Investment Management,Inc.
6.55%
RGM Capital LLC
6.49%
Dimensional Fund Advisors, Inc.
5.60%
State Street Corp
4.26%

Analyst Recommendation on Avanos Medical

Buy

66%Buy

33%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Avanos Medical(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Avanos Medical Stock (AVNS)

What analysts predicted

Upside of 14.71%

Target:

$17.00

Current:

$14.82

Insights on Avanos Medical Stock (Ticker Symbol: AVNS)

Price Movement
In the last 6 months, AVNS stock has moved down by -38.6%
Increasing Revenue
Revenue is up for the last 2 quarters, 170.4M → 179.6M (in $), with an average increase of 5.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 4.3M → -397.3M (in $), with an average decrease of 9339.5% per quarter
AVNS vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 49.4% return, outperforming this stock by 73.6%
AVNS vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 127.8% return, outperforming this stock by 182.2%
Price to Sales
ForAVNS every $1 of sales, investors are willing to pay $1.0, whereas for Boston Scientific Corp., the investors are paying $8.9 for every $1 of sales.

AVNS Avanos Medical Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$697.6M	↑ 6.94%
Net Income	$-45.9M	↓ 179.83%
Net Profit Margin	-6.58%	↓ 15.39%

	FY20	Y/Y Change
Revenue	$714.8M	↑ 2.47%
Net Income	$-27.2M	↓ 40.74%
Net Profit Margin	-3.81%	↑ 2.77%

	FY21	Y/Y Change
Revenue	$744.6M	↑ 4.17%
Net Income	$6.3M	↓ 123.16%
Net Profit Margin	0.85%	↑ 4.66%

	FY22	Y/Y Change
Revenue	$820.0M	↑ 10.13%
Net Income	$50.5M	↑ 701.59%
Net Profit Margin	6.16%	↑ 5.31%

	FY23	Y/Y Change
Revenue	$673.3M	↓ 17.89%
Net Income	$-61.8M	↓ 222.38%
Net Profit Margin	-9.18%	↓ 15.34%

	FY24	Y/Y Change
Revenue	$687.8M	↑ 2.15%
Net Income	$-392.1M	↑ 534.47%
Net Profit Margin	-57.01%	↓ 47.83%

	Q3 FY23	Q/Q Change
Revenue	$171.3M	↑ 1.12%
Net Income	$-3.7M	↓ 94.57%
Net Profit Margin	-2.16%	↑ 38.04%

	Q4 FY23	Q/Q Change
Revenue	$173.3M	↑ 1.17%
Net Income	$10.5M	↓ 383.78%
Net Profit Margin	6.06%	↑ 8.22%

	Q1 FY24	Q/Q Change
Revenue	$166.1M	↓ 4.15%
Net Income	$-900.0K	↓ 108.57%
Net Profit Margin	-0.54%	↓ 6.6%

	Q2 FY24	Q/Q Change
Revenue	$171.7M	↑ 3.37%
Net Income	$1.8M	↓ 300.0%
Net Profit Margin	1.05%	↑ 1.59%

	Q3 FY24	Q/Q Change
Revenue	$170.4M	↓ 0.76%
Net Income	$4.3M	↑ 138.89%
Net Profit Margin	2.52%	↑ 1.47%

	Q4 FY24	Q/Q Change
Revenue	$179.6M	↑ 5.4%
Net Income	$-397.3M	↓ 9339.53%
Net Profit Margin	-221.21%	↓ 223.73%

	FY19	Y/Y Change
Profit	$402.2M	↑ 2.89%

	FY20	Y/Y Change
Profit	$373.3M	↓ 7.19%

	FY21	Y/Y Change
Profit	$364.3M	↓ 2.41%

	FY22	Y/Y Change
Profit	$450.0M	↑ 23.52%

	FY23	Y/Y Change
Profit	$379.7M	↓ 15.62%

	FY24	Y/Y Change
Profit	$381.3M	↑ 0.42%

	Q3 FY23	Q/Q Change
Profit	$95.5M	↓ 2.35%

	Q4 FY23	Q/Q Change
Profit	$97.4M	↑ 1.99%

	Q1 FY24	Q/Q Change
Profit	$94.8M	↓ 2.67%

	Q2 FY24	Q/Q Change
Profit	$95.6M	↑ 0.84%

	Q3 FY24	Q/Q Change
Profit	$92.9M	↓ 2.82%

	Q4 FY24	Q/Q Change
Profit	$98.0M	↑ 5.49%

	FY19	Y/Y Change
Operating Cash Flow	$-74.5M	↓ 48.83%
Investing Cash Flow	$-108.1M	↓ 116.9%
Financing Cash Flow	$1.5M	↓ 100.46%

	FY20	Y/Y Change
Operating Cash Flow	$-2.5M	↓ 96.64%
Investing Cash Flow	$-24.2M	↓ 77.61%
Financing Cash Flow	$-70.0M	↓ 4766.67%

	FY21	Y/Y Change
Operating Cash Flow	$87.3M	↓ 3592.0%
Investing Cash Flow	$-21.0M	↓ 13.22%
Financing Cash Flow	$-55.3M	↓ 21.0%

	FY22	Y/Y Change
Operating Cash Flow	$90.9M	↑ 4.12%
Investing Cash Flow	$-135.4M	↑ 544.76%
Financing Cash Flow	$56.7M	↓ 202.53%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$29.1M	↓ 1219.23%
Investing Cash Flow	$-48.9M	↑ 652.31%
Financing Cash Flow	$46.7M	↓ 1239.02%

Avanos Medical Technicals Summary

Sell

Neutral

Buy

Avanos Medical is currently in a neutral trading position according to technical analysis indicators.

Avanos Medical (AVNS) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Avanos Medical, Inc.	-4.57%	-39.98%	-24.16%	-53.92%	-28.2%
Medtronic Plc	6.74%	2.68%	9.32%	-15.52%	25.99%
Edwards Lifesciences Corp.	-6.3%	5.41%	-23.8%	-36.44%	35.28%
Boston Scientific Corp.	-4.39%	20.33%	49.36%	127.28%	289.97%
Abbott Laboratories	-2.12%	11.63%	14.28%	4.65%	102.83%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Avanos Medical, Inc.	33.23	NA	NA	1.13	-0.37	0.02	NA	18.03
Medtronic Plc	28.01	28.01	1.59	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	30.04	30.04	5.49	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	80.58	80.58	1.95	2.86	0.09	0.05	NA	14.76
Abbott Laboratories	16.53	16.53	4.17	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Avanos Medical, Inc.	Buy	$681.8M	-28.2%	33.23	-57.01%
Medtronic Plc	Buy	$117.8B	25.99%	28.01	12.83%
Edwards Lifesciences Corp.	Buy	$41.7B	35.28%	30.04	76.75%
Boston Scientific Corp.	Buy	$148.7B	289.97%	80.58	11.07%
Abbott Laboratories	Buy	$221.0B	102.83%	16.53	31.95%

About Avanos Medical

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Organization	Avanos Medical
Employees	2227
CEO	Ms. Siobhan Smyth
Industry	Health Technology

Management People of Avanos Medical

Name	Title
Ms. Siobhan Smyth	VP & Chief Information Officer
Mr. Jonathan Turner	VP and Chief Ethics & Compliance Officer
Ms. Katrine Kubis	Vice President of Corporate Communications & Community Relations
Mr. Scott Galovan	Senior Vice President of Strategy & Corporate Development
Mr. John W. Cato	Vice President of Global Human Resources
Mr. Lee Burnes	Senior Vice President of Global R&D, Clinical and Medical Affairs
Mr. Vinny Sastri	Senior Vice President of Quality
Mr. Chip Zimliki	Senior Vice President of Regulatory & Clinical Affairs
Mr. John Joseph Hurley	Controller

Important FAQs about investing in AVNS Stock from India :

What is Avanos Medical share price today?

Avanos Medical share price today stands at $14.82, Open: $14.62 ; Previous Close: $14.63 ; High: $14.84 ; Low: $14.48 ; 52 Week High: $25.36 ; 52 Week Low: $14.25.

The stock opens at $14.62, after a previous close of $14.63. The stock reached a daily high of $14.84 and a low of $14.48, with a 52-week high of $25.36 and a 52-week low of $14.25.

Can Indians buy Avanos Medical shares?

Yes, Indians can invest in the Avanos Medical (AVNS) from India.

With INDmoney, you can buy Avanos Medical at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Avanos Medical at zero transaction cost.

How can I buy Avanos Medical shares from India?

It is very easy to buy Avanos Medical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Avanos Medical (AVNS) be purchased?

Yes, you can buy fractional shares of Avanos Medical with INDmoney app.

What are the documents required to start investing in Avanos Medical stocks?

To start investing in Avanos Medical, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.